[1] | Vignon, J., Privat, A. , Chaudieu, I., Thierry, A., Kamenka, J.M., and Chicheportiche, R. : [3H] thienyl-phencyclidine binds to two different sites in rat brain. Brain Res. 378 : 133-141, 1986 |
[2] | Madelmont, J.C., Godeneche, B., Labarre, P., Thierry, A., and Veyre, A. : Comparative study of the efficiency of 2-chloroethyl and 2-fluoroethyl nitrosoureas. Eur. J. Med. Chem. 22 : 261-264, 1987 |
[3] | Thierry, A. and Chicheportiche, R. : Use of ATP bioluminescence measurements for the estimation of biomas during biological humification. Appl. Microbiol Biotechnol. 28 : 199-202, 1988 |
[4] | Thierry, A. Doly, M., Braquet, P., Cluzel, J., and Meyniel, G.: Presence of specific platelet-activating factor binding sites in the rat retina. Eur. J. Pharmacol. 163 : 97-101, 1989 |
[5] | Thierry, A., Jorgensen, T., Forst, D., Belli, J.A.., Dritschilo, A., and Rahman, A. : Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin. Cancer Commun. 1 : 311-316, 1989. |
[6] | Godeneche, D., Rapp, M. Thierry, A., Laval, F., Madelmont, J.C., Chollet, P. and Veyre, A. : DNA damage induced by a new chloroethyl nitrosourea on malignant melanoma cells. Cancer Res. 50 : 5898-5903, 1990. |
[7] | Thierry, A.R., Dritschilo, A., and Rahman, A. : Liposomal carrier system as a novel approach to transport ologonucleotides into cells. Proc. Am. Assoc. Cancer Res. 31/2642, 1990 |
[8] | Oudard, S., Thierry, A., Jorgensen, T.J., and Rahman, A : Senzitization of multidrug-resistant colon cancer cell lines to doxorubicin encapsulated in liposome. Cancer Chemother. Pharmacol. 28: 259-265, 1991 |
[9] | Thierry, A.R., and Dritschilo, A.: Intracellular avaibility of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res. 21: 5691-5698, 1992 |
[10] | Thierry, A.R., Dritschilo, A. and Rahman, A : Effect of liposomes on P-glycoprotein function in multidrug resistance cells. Biochem. Biophys. Res. Commun. 187 : 1098-1105, 1992 |
[11] | Thierry, A.R., and Dritschilo, A. : Liposomal delivery of antisense oligodeoxynucleotides : Application to the modulation of multidrug resistance in cancer cells. Ann. NY Acad. Sci. 660 : 300-302, 1992 |
[12] | Thierry, A.R. Rahman, A. , and Dritschilo, A. : Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. Biochem. Biophys. Res. Commun. 190 : 952-960, 1993 |
[13] | Thierry, A.R., Bradley, M.O., and Chrisey, L.A.: Progress in antisense research and development. Antisense Res. Dev. 3 : 411-416, 1993 |
[14] | Thierry, A.R., Vige, D., Belli, J.A., Dritschilo, A. , and Rahman, A. : Modulation of doxorubicin resistance in multidrug resistance cancer cells by liposomes. FASEB. J. 7572-579, 1993 |
[15] | Rahman, A., Thierry, A.R., Husain, S.R., and Dritschilo, A.: Clinical evaluation of liposome encapsulated doxorubicin and the modulation of multidrug resistance in cancer cells. J. Liposome Res. 4 : 167-192, 1994 |
[16] | Lisziewicz, J. Sun, D. Weichold, F.F., Thierry, A.R., Lusso, P. Tang, J. Gallo, R.C., and Agrawal, S. : Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells; Proc. Natl. Acad. Sci. USA 91, 7942-7946, 1994 |
[17] | Thierry, A.R., Bryant, J.L., Aksentijevich, I. et al : Transgene expression in mice using a new liposomal delivery system. AIDS Res. Hum. Retrov. 10, sup 3, 1994. |
[18] | Lunardi-Iskandar, Y., Bryant, J.L., Zeman, R.A., Lam, V.H. Samaniego, F. Besnier, J.M., Hermans, P. Thierry, A.R., Gill, P., and Gallo, R.C.: Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immonodeficient mice blocked by an human pregnancy hormone. Nature 375 : 64-68, 1995. |
[19] | Thierry, A.R., Rahman, A., and Dritschilo, A. : A new procedure for the preparation of liposomal doxorubicin : biological activity in multidrug-resistant tumor cells. Cancer Chemother. Pharmacol. 35, 84-88, 1994. |
[20] | Thierry, A.R., Zeman, R.A., Hunh, J.W., Bryant, J.L., Gallo, R.C. and Lunardi-Iskandar, Y. : In vitro and in vivo inhibition of tumorigenicity of neoplastic Kaposi's sarcoma cell line (KS Y-1) by liposomal IL-6, IL-8 and VEGF antisense oligodeoxynucleotides. Proc. Am. Assoc. Cancer. Res. 36, 413, 1995. |
[21] | Thierry, A.R., Lunardi-Iskandar, Y, Bryant, J.L., Rabinovitch, P., Gallo, R.C., and Mahan, L.C. : Systemic gene therapy : biodistribution and long-term expression of a transgene in mice. Proc. Natl. Acad. Sci. USA. 92, 9742-9746, 1995. |
[22] | Aksentijevish, I. Pastan, Y. Lunardi-Iskandar, R. C. Gallo, M. M. Gottesman, and A. R. Thierry. In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells. Human Gene Ther. 7:1111-1122, 1996. |
[23] | M. Baudard, T.R. Flotte, J.M. Arian, A.R. Thierry, I.Pastan, M.G. Pang, W.G. Kearns, M.M Gottesman. Expression of the Human Multidrug Resistance and Glucocerebrosidase cDNAS from Adeno-Associated Vectors : Efficient Promoter Activity of AAV Sequences and in vivo Delivery via liposomes. Human. Gene Ther. 7 :1309-1322, July 10, 1996. |
[24] | A.R. Thierry, P. Rabinovich, B. Peng, L. C. Mahan, J. L. Bryant, and R. C. Gallo. Characterization of liposome-mediated gene delivery : Expression, stability and pharmacokinetics of plasmid DNA. Gene Therapy 4:226-237, 1997. |
[25] | C. Lavigne and A.R. Thierry. Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system. Biochem.Biophys.Res.Comm. 237 (3):566-571, 1997. |
[26] | G. B. Takle, A. R. Thierry, S. M. Flynn, B. Peng, L. White, W. Devonhish, R. A. Galbraith, A. R. Goldberg, and S. T. George. Delivery of oligoribonucleotides to human hepatoma cells using cationic lipid particles conjugated to ferric protoporphyrin IX (heme). Antisense Nucl.Acid Drug Devlpt. 7:177-185, 1997. |
[27] | A.R. Thierry. Optimization of lipoplex formulations for intravenous gene delivery. J.Liposome Res. 7:143-159, 1997. |
[28] | Felgner, P.L., Barenholz, Y., Behr, J.P., Cheng, S.H., Cullis, P., Huang, L., Jessee, J.A., Seymour, L., Szoka, F., Thierry, A.R., Wagner, E., and Wu, G. Nomenclature for synthetic gene delivery systems. Hum. Gene Ther. 8, 511-512, 1997. |
[29] | O. A. Sedelnikova, I. G. Panyutin, A. R. Thierry, and R. D. Neumann. Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells. J.Nucl.Med. 39 (8):1412-1417, 1998. |
[30] | F. Samaniego, J.L. Bryant, N. Liu, J.E. Karp, A .R. Thierry, Y. Lunardi-Iskandar, R.C. Gallo. Induction of program cell death in Kaposi's Sarcoma cells by preparations of human corionic gonadotropin. J. NCI. 91, 135-142, 1999. |
[31] | M. Schmutz, D. Durand, Y, Palvadeau, A. Debin, A. Etienne, A.R. Thierry. DNA packing in stable lipid complexes designed for gene transfer imitates DNA compaction in bacteriophages. Proc. Nat. Acad. Sci. USA 96, 12293-12298, 1999. |
[32] | C. Lavigne, J. Yelle, G. Sauvé, A.R. Thierry. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication. AAPS Pharm. Sci. 3, article 7. 2001. |
[33] | B. Tavitian, S. Marzabal, V. Boutet, B. Kuhnast, S. Terrazino, M. Moynier, F. Dollé, J.R. Deverre, A.R. Thierry. Characterization of a synthetic anionic vector for oligonucleotide Delivery using in vivo whole body dynamic imaging. Pharm. Res. 19, 367-376, 2002. |
[34] | C. Lavigne, J. Yelle, G. Sauvé, A.R. Thierry. On the sequence specific activity of antisense oligonucleotides aimed at the inhibition of HIV-1 replication. AAPS Pharm. Sci., 4 article 9, (http ://www.pharmsci.org/) (2002). |
[35] | A.R. Thierry, E. Vives, J.P. Richard, P. Prevot, C. Martinand-Mari, I. Robbins, B. Lebleu. Cellular Uptake and intracellular fate of antisense oligonucléotides. Current Op. Mol. Ther. 5, 133-138, (2003). |
[36] | C. Lavigne, Y. Lunardi-Iskandar, B Lebleu, and A. R. Thierry. Cationic Liposomes/Lipids for Oligonucleotide Delivery: Application to the Inhibition of Tumorigenicity of Kaposi's Sarcoma by VEGF Antisense Oligodeoxynucleotides. Method Enzymol. 387, 189-210 (2004) |
[37] | F.Maurel, F. Debart, F. Cavelier, A.R. Thierry, Lebleu Bernard, J.J Vasseur and E. Vivès. High yield synthesis of peptide-oligonucleotide chimera through a disulfide bridge: a simplified method for oligonucleotide activation. Bioconjugate Chem., in press; available online via ScienceDirect DOI information: 10.1016/j.bmcl.2005.07.086 (2005) |
[38] | Abes, S., Williams, D., Prevot, A. Thierry, P., Gait, M. J., and Lebleu, B. Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates, J Control Release 110(3):595-604 (2006) |
[39] | A.R. Thierry, S. Abes, S. Resina, A. Travo, J.P. Richard, P. Prevot and B. Lebleu. Comparison of basic peptides-and lipid-based strategies for the delivery of splice correcting oligonucleotides. Biochim.Biophys.Acta, 1758(3):364-74 (2006) |
[40] | A.R. Thierry, F. Kepes, P. Amar, G. Barlovatz, G. Bernot, C. Froidevaux, J.L. Giavitto, J. Guespin, V. Norris, V. Schafter, C. Godin and F. Molina. Modelling of biological complex systems in the context of genomics, J. Biol.Phys.Chem. 6, 103-107 (2006). |
[41] | S. Resina, S. Abes, A. Travo, P. Clair, P. Prevot, R. Kole, B. Lebleu and A. R. Thierry. Switching on transgene expression by correcting aberrant splicing with using multi-targeting steric block oligonucleotides. J. Gene Med. 9, 498-510 (2007). |
[42] | M. Meryet-Figuières, S. Resina, C. Lavigne, G. Barlovatz-Meimon, B. Lebleu and A.R. Thierry. Inhibition of PAI-1 Expression in Breast Cancer Carcinoma Cells by siRNA. Biochimie 89, 1228-1233 (2007) |
[43] | Resina S., Abes S., Turner J.J., Prevot P., Travo A., Clair P., Gait M.J., Thierry A.R., Lebleu B. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides. Int J Pharm. 2007 May 17; [Epub ahead of print] |
[44] | C. Lavigne and A.R. Thierry. Specific subcellular localization of siRNAs delivered by lipoplex in MCF-7 breast cancer cells. Biochimie, 89, 1245-1251 (2007) |
[45] | Lavigne, C., Guignee, A., and Thierry, A. R. (2008) A rapid microwell fluorescence immunoassay for cellular protein detection. Biol Proced Online 10, 83-9. |
[46] | Resina, S., Prevot, P., and Thierry, A. R. (2009) Physico-chemical characteristics of lipoplexes influence cell uptake mechanisms and transfection efficacy. PLoS One 4, e6058. |
[47] | Thierry, A. R., Norris, V., Molina, F., and Schmutz, M. (2009) Lipoplex nanostructures reveal a general self-organization of nucleic acids. Biochim Biophys Acta 1790, 385-94. |
[48] | Rialle, S., Felicori, L., Dias-Lopes, C., Pérès, S., El Atia, S., Thierry, A.R., Amar, P. and Molina, F. (2010). BioNetCAD: design, simulation and experimental validation of synthetic biochemical networks. Bioinformatics 26(18): 2298-304 |
[49] | Maltais M., Thierry A. R., Blessing T., Maicas E., Vert M. and Lavigne C. (2010) A biodegradable hydrogel as a cell delivery carrier for autologous tumor cell vaccines. Int.J.Oncol. 36, 617-622. |
[50] | Thierry, A. R., Mouliere, F., Gongora, C., Ollier, J., Robert, B., Ychou, M., Del Rio, M., and Molina, F. (2010) Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res 38, 6159-75. |
[51] | Arnau Peyrotte E., Mouliere, F., Gongora, C., Robert, B., Ychou, M., Del Rio, M., Molina, F and Thierry, A. R., , Study of the origin and quantification of circulating DNA in colorectal cancer mouse xenografts and patients: application to diagnosis, Bull. Cancer. 2010. 97: S48-49. |
[52] | Norris, V., Zemirline, A., Amar, P., Audinot, J. N., Ballet, P., Ben-Jacob, E., Bernot, G., Beslon, G., Cabin, A., Fanchon, E., Giavitto, J. L., Glade, N., Greussay, P., Grondin, Y., Foster, J. A., Hutzler, G., Jost, J., Kepes, F., Michel, O., Molina, F., Signorini, J., Stano, P., and Thierry, A. R. (2010) Computing with bacterial constituents, cells and populations: from bioputing to bactoputing. Theory Biosci. |
[53] | Lavigne, C, Slater, K, Duguay C, Arnau Peyrotte, E, Fortier G, Simard, M, Thierry AR Influence of lipoplex surface charge on siRNA delivery: Application to the in vitro downregulation of CXCR4 HIV-1 co-receptor, Molecular Pharmaceutics, accepted |
[54] | Mouliere, F., Gongora, C., Robert, B., Pezet, D., Lamy, P.J., Crapez, E., Ychou, M., Del Rio, M., Molina, F and Thierry, A. R., , High fragmentation characterizes tumour-derived circulating DNA, PlosOne, accepted |